We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

169 hedge funds and large institutions have $655M invested in Ariad Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 44

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

0% more funds holding

Funds holding: 169 → 169 (0)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

17% less capital invested

Capital invested by funds: $790M → $655M (-$135M)

23% less call options, than puts

Call options by funds: $20.5M | Put options by funds: $26.5M

Holders
169
Holders Change
–
Holders Change %
0%
% of All Funds
4.9%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
25
Increased
61
Reduced
44
Closed
24
Calls
$20.5M
Puts
$26.5M
Net Calls
-$6.01M
Net Calls Change
-$11M

Top Buyers

Rank Fund Capital Flow
1
CCI
Columbus Circle Investors
+$13.6M
2
PC
PointState Capital
New York
+$10.5M
3
DFO
Duquesne Family Office
New York
+$9.61M
4
O
OppenheimerFunds
New York
+$9.46M
5
Millennium Management
Millennium Management
New York
+$8.33M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$32.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$22M
3
Renaissance Technologies
Renaissance Technologies
New York
-$18.4M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$14.2M
5
Norges Bank
Norges Bank
Norway
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
LTFS
101
Ladenburg Thalmann Financial Services
Florida
$245K +$172K +29,516 +186%
Wellington Management Group
102
Wellington Management Group
Massachusetts
$238K +$258K +44,100 New
William Blair & Company
103
William Blair & Company
Illinois
$236K +$146K +24,980 +134%
CWM
104
Concert Wealth Management
California
$229K +$2.19K +375 +0.9%
AG
105
Aperio Group
California
$223K +$76.9K +13,167 +47%
HW
106
Hancock Whitney
Mississippi
$216K – – –
QC
107
QCM Cayman
Texas
$209K +$148K +25,305 +190%
QT
108
Quantbot Technologies
New York
$204K -$82 -14 -0%
Commonwealth Equity Services
109
Commonwealth Equity Services
Massachusetts
$196K -$192K -32,950 -48%
Principal Financial Group
110
Principal Financial Group
Iowa
$185K – – –
NPC
111
National Planning Corporation
California
$178K +$181K +31,000 New
Credit Agricole
112
Credit Agricole
France
$173K +$81.8K +14,011 +78%
CAM
113
Congress Asset Management
Massachusetts
$162K – – –
N
114
Natixis
France
$162K – – –
HSBC Holdings
115
HSBC Holdings
United Kingdom
$155K +$9.89K +1,693 +6%
Legal & General Group
116
Legal & General Group
United Kingdom
$149K +$154K +26,388 New
M&T Bank
117
M&T Bank
New York
$147K +$158K +27,102 New
Royal Bank of Canada
118
Royal Bank of Canada
Ontario, Canada
$145K +$78.3K +13,415 +100%
Prudential Financial
119
Prudential Financial
New Jersey
$123K -$128K -21,900 -49%
SEC
120
Seven Eight Capital
New York
$118K +$61.8K +10,577 +94%
Parallax Volatility Advisers
121
Parallax Volatility Advisers
California
$113K -$28.5K -4,873 -19%
WPP
122
Whalerock Point Partners
Rhode Island
$97K +$105K +18,000 New
Creative Planning
123
Creative Planning
Kansas
$95K +$34.5K +5,910 +51%
AB
124
Amalgamated Bank
New York
$87K -$41 -7 -0%
ACM
125
Apex Capital Management
Ohio
$85K +$92.4K +15,824 New
3 4
5
6 7

ARIA Hedge Fund Activity: Q3 2014 in Review

169 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2014, worth a combined $655M — down 17% from $790M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ARIA positions and 24 closed out — a net gain of 1 holder — while 61 added to existing stakes and 44 trimmed.

The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $13.6M. The largest seller was Franklin Resources, exiting entirely with an estimated $32.1M sold.

  • 169 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $655M of Ariad Pharmaceuticals Inc stock for Q3 2014, down 17% quarter-over-quarter.
  • 25 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2014 and 24 closed out, a net change of +1 holder.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2014 was Columbus Circle Investors, an estimated $13.6M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $32.1M sold.

Based on aggregated 13F filings for Q3 2014.